Back to search
FDAFDA · Food and drugs·Recall number D-0590-2024

buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 60687-782-01.

Published July 17, 2024 · Recall initiated: June 24, 2024

Summary

FDA records drug Class II recall D-0590-2024, published July 17, 2024 and initiated June 24, 2024. Recalling firm: Amerisource Health Services LLC; Status: Ongoing; Reported quantity: 2,484 cartons; Lot: Lot 1017343, Exp. 12/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications; the product is dissolving faster than the specified limits.

What to do

Voluntary: Firm initiated · Letter

Get an email if BUPROPION HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BUPROPION HYDROCHLORIDE
Manufacturer
Amerisource Health Services LLC
Distributor
Nationwide in the USA
Lot
Lot 1017343, Exp. 12/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 60687-782-01. recalled?

Yes. FDA published recall D-0590-2024 on July 17, 2024. Reported hazard: Failed Dissolution Specifications; the product is dissolving faster than the specified limits.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BUPROPION HYDROCHLORIDE.